Symbol="ORMP"
AssetType="Common Stock"
Name="Oramed Pharmaceuticals Inc"
Description="Oramed Pharmaceuticals Inc. is dedicated to the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for the administration of polypeptides. The company is headquartered in New York, New York."
CIK="1176309"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="HI-TECH PARK 2/4 GIVAT-RAM, PO BOX 39098, JERUSALEM, IL"
FiscalYearEnd="August"
LatestQuarter="2023-02-28"
MarketCapitalization="138895000"
EBITDA="-34470000"
PERatio="None"
PEGRatio="0"
BookValue="3.777"
DividendPerShare="0"
DividendYield="0"
EPS="-0.72"
RevenuePerShareTTM="0.069"
ProfitMargin="0"
OperatingMarginTTM="-12.78"
ReturnOnAssetsTTM="-0.13"
ReturnOnEquityTTM="-0.196"
RevenueTTM="2703000"
GrossProfitTTM="2703000"
DilutedEPSTTM="-0.72"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="3.15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="117.98"
PriceToBookRatio="2.088"
EVToRevenue="60.11"
EVToEBITDA="-6.13"
Beta="1.75"
num_52WeekHigh="13.73"
num_52WeekLow="1.81"
num_50DayMovingAverage="3.542"
num_200DayMovingAverage="4.802"
SharesOutstanding="40027400"
DividendDate="None"
ExDividendDate="None"
symbol="ORMP"
open="3.38"
high="3.52"
low="3.37"
price="3.47"
volume="234526.00"
latest_trading_day="2023-07-07"
previous_close="3.40"
change="0.07"
change_percent="2.0588%"
aroon_positive_momentum_days="59"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="59"
Volume_recent_avg="818517"
Change_recent_avg="0.01"
Delta_recent_avg="0.2"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="0.28"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="59"
Aroon_momentum_negative="41"
image_negative_thumbnail_id_1="150"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0026.jpeg"
image_negative_thumbnail_id_2="151"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0025.jpeg"
image_neutral_thumbnail_id_1="598"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_neutral_thumbnail_id_2="589"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_positive_thumbnail_id_1="989"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_positive_thumbnail_id_2="662"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
